Royce & Associates LP Has $94.47 Million Holdings in Innospec Inc. (NASDAQ:IOSP)

Royce & Associates LP raised its holdings in Innospec Inc. (NASDAQ:IOSP) by 9.3% during the third quarter, Holdings Channel.com reports. The fund owned 835,333 shares of the specialty chemicals company’s stock after purchasing an additional 70,902 shares during the period. Innospec comprises about 0.9% of Royce & Associates LP’s holdings, making the stock its 7th largest holding. Royce & Associates LP’s holdings in Innospec were worth $94,468,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of IOSP. DekaBank Deutsche Girozentrale bought a new stake in shares of Innospec in the 1st quarter valued at about $66,000. CWM LLC lifted its holdings in Innospec by 239.6% during the second quarter. CWM LLC now owns 635 shares of the specialty chemicals company’s stock worth $78,000 after acquiring an additional 448 shares in the last quarter. Blue Trust Inc. grew its stake in Innospec by 503.9% in the third quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company’s stock valued at $96,000 after acquiring an additional 650 shares during the period. nVerses Capital LLC increased its holdings in shares of Innospec by 200.0% in the third quarter. nVerses Capital LLC now owns 900 shares of the specialty chemicals company’s stock worth $102,000 after acquiring an additional 600 shares in the last quarter. Finally, Motco acquired a new stake in shares of Innospec during the first quarter worth about $132,000. Institutional investors and hedge funds own 96.64% of the company’s stock.

Innospec Stock Up 0.1 %

Shares of NASDAQ:IOSP opened at $121.85 on Friday. The firm has a market cap of $3.04 billion, a price-to-earnings ratio of 21.27 and a beta of 1.08. Innospec Inc. has a 12 month low of $103.97 and a 12 month high of $133.71. The company’s fifty day simple moving average is $112.24 and its 200 day simple moving average is $118.84.

Innospec (NASDAQ:IOSP) last issued its quarterly earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 EPS for the quarter, meeting analysts’ consensus estimates of $1.35. The company had revenue of $443.40 million for the quarter, compared to analyst estimates of $442.13 million. Innospec had a return on equity of 13.33% and a net margin of 7.68%. The company’s quarterly revenue was down 4.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.59 earnings per share. Research analysts expect that Innospec Inc. will post 5.88 earnings per share for the current fiscal year.

Innospec Increases Dividend

The firm also recently declared a Semi-Annual dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Monday, November 18th will be paid a dividend of $0.79 per share. This is a boost from Innospec’s previous Semi-Annual dividend of $0.72. This represents a dividend yield of 1.3%. The ex-dividend date is Monday, November 18th. Innospec’s dividend payout ratio (DPR) is currently 26.53%.

Insider Transactions at Innospec

In related news, Director Milton C. Blackmore sold 1,035 shares of Innospec stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $122.92, for a total value of $127,222.20. Following the sale, the director now owns 9,028 shares of the company’s stock, valued at approximately $1,109,721.76. The trade was a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Ian Cleminson sold 3,398 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $114.74, for a total value of $389,886.52. Following the transaction, the chief financial officer now directly owns 12,996 shares of the company’s stock, valued at $1,491,161.04. This trade represents a 20.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 11,035 shares of company stock valued at $1,267,096 over the last 90 days. 1.52% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered Innospec from a “strong-buy” rating to a “buy” rating in a research report on Thursday, August 8th.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.